Windtree Therapeutics, Inc. (WINT)

0.0003 0.00 (0.00%) USD  |  OTCM  |  Oct 02, 16:00
More

Windtree Therapeutics EPS Diluted (Quarterly) : -1.085 for Sept. 30, 2025

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2025 -1.085
June 30, 2025 -3.059
March 31, 2025 -4.633
December 31, 2024 0.265
September 30, 2024 -211.39
June 30, 2024 -1045.56
March 31, 2024 1098.83
December 31, 2023 -773.54
September 30, 2023 -773.60
June 30, 2023 -1474.17
March 31, 2023 -4287.26
December 31, 2022 -11295.90
September 30, 2022 -5862.15
June 30, 2022 -26712.00
March 31, 2022 -12924.90
December 31, 2021 -20861.10
September 30, 2021 -13840.20
June 30, 2021 -63852.30
March 31, 2021 -22788.45
December 31, 2020 -19848.15
September 30, 2020 -24482.70
June 30, 2020 -28501.20
March 31, 2020 -21466.35
December 31, 2019 -28777.95
September 30, 2019 -29886.30
Date Value
June 30, 2019 -26997.30
March 31, 2019 -27456.30
December 31, 2018 -436764.2
September 30, 2018 -140659.2
June 30, 2018 -109842.8
March 31, 2018 -188757.0
December 31, 2017 114484.1
September 30, 2017 -28.43M
June 30, 2017 -2.052M
March 31, 2017 -3.699M
December 31, 2016 -2.162M
September 30, 2016 -2.700M
June 30, 2016 -3.483M
March 31, 2016 -4.590M
December 31, 2015 -3.402M
September 30, 2015 -7.759M
June 30, 2015 -4.914M
March 31, 2015 -5.292M
December 31, 2014 -5.670M
September 30, 2014 -4.914M
June 30, 2014 -5.292M
March 31, 2014 -5.292M
December 31, 2013 -6.048M
September 30, 2013 -8.316M
June 30, 2013 -6.539M

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Navidea Biopharmaceuticals, Inc. --
Biostax Corp. --
GeneLink, Inc. --
NovAccess Global, Inc. --
Trevena, Inc. --

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -28.08M
Total Expenses (Quarterly) 28.08M